Nov 6 (Reuters) - Viking Therapeutics Inc VKTX.O:
VIKING THERAPEUTICS HIGHLIGHTS CLINICAL DATA FROM VK2735 OBESITY PROGRAM IN PRESENTATION AT OBESITYWEEK® 2025
Source text: ID:nPn6RHRxKa
Further company coverage: VKTX.O
((Reuters.Briefs@thomsonreuters.com;))